Mankind Pharma (BOM:543904) Short-Term Capital Lease Obligation : ₹34 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Short-Term Capital Lease Obligation?

Mankind Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹34 Mil.

Mankind Pharma's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (₹32 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹34 Mil).

Mankind Pharma's annual Short-Term Capital Lease Obligation declined from Mar. 2022 (₹21 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹34 Mil).

Mankind Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mankind Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Short-Term Capital Lease Obligation Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Capital Lease Obligation

11.40

16.22

20.57

34.23

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							-	-	32.21	-	34.23

Mankind Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mankind Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines